IN VIVO CRO MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

In Vivo CRO Market, By Type of Molecule (Small Molecules and Large Molecules), By Therapeutic Area (Oncology, Cardiology, Diabetes, Autoimmune/inflammation conditions, Infectious Diseases, CNS Conditions, and Others), By Service Type (Preclinical Testing, Clinical Research Services, Laboratory Services, Consulting Services, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

In March 2022, eTheRN, a biotechnology company launched a new service for developing and producing Lipid Nanoparticle (LNP) formulations. This service aims to assist in the discovery and early pre-clinical development of RNA-based therapeutics and vaccines.
In November 2023, Charles River Laboratories, a U.S.-based pharmaceutical company, revealed a collaboration with Aitia, biosimulation compan focused on drug development and in vivo oncology research
In March 2023, Biocytogen Boston Corp, a pharmaceutical company, announced a licensing agreement with Janssen Biotech, Inc., granting Janssen Biotech, Inc. rights to utilize the RenLite platform
In January 2023, Evotec SE, a drug discovery and development company, forged a partnership with Janssen Biotech, a biotech company, to advance immune-based therapies targeting oncology